On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayMar 08, 2018 8:30 am

NetworkNewsAudio – Epazz, Inc. (EPAZ) Set to Benefit as Blockchain Popularity Rises

Related Editorial Blockchain technology has taken the world by storm. From its initial use as the technological architecture underlying cryptocurrencies such as Bitcoin, the technology has grown in popularity to the point that now an ever-increasing number of industries and applications around the globe make use of the innovative distributed ledger. Each day, the value of blockchain technology gains further ground as its myriad of potential applications attract the interest of new developers, users, and investors. Epazz, Inc. (OTC: EPAZ) (EPAZ Profile), SinglePoint, Inc. (OTCQB: SING) (SING Profile), Bitcoin Services, Inc. (OTC: BTSC), Glance Technologies, Inc. (OTCQB: GLNNF), and HashChain…

Continue Reading

MondayMar 05, 2018 8:30 am

NetworkNewsAudio – Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF) Files Patent Application

Related Press Release NeutriSci International Inc. (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the filing of a new U.S. provisional patent application (United States Provisional Patent No. 62/628,735; Compositions Comprising Co-crystals of Stilbenoids and Cannabinoids) relating to compositions comprising pterostilbene and other stilbenoids in formulations which improve the dissolution rate and bioavailability of cannabinoid compounds. View Original Press Release

Continue Reading

MondayMar 05, 2018 8:30 am

NetworkNewsAudio – Earth Science Tech, Inc. (ETST) Finalizes Plans for Human Trials on New CBD-Based Formula Targeting Opioid Addiction Epidemic

Related Press Release Earth Science Tech, Inc. (OTC: ETST), an innovative biotech company focused on the cannabinoid ("CBD"), nutraceutical and pharmaceutical fields, as well as on R&D for certain medical devices, today announces that it has finalized the plans for its previously announced human trial to assess the efficacy of the combination of an essential mineral element and full-spectrum cannabinoid industrial hemp oil. The purpose of this nine-month trial is to develop a CBD formulation and methodology for treating opioid addicts, preventing fatal overdoses, and relieving side-effects from withdrawals. View Original Press Release

Continue Reading

FridayMar 02, 2018 8:30 am

NetworkNewsAudio – PreveCeutical Medical, Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) Explores Potential of Gene Therapy to Treat Diabetes

Related Editorial Since its first successful use nearly 30 years ago, gene therapy has grown into an important if experimental part of the medical sector. Now it is taking off in a big way, offering treatment for chronic ailments such as diabetes and other conditions. PreveCeutical Medical, Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (PRVCF Profile) is at the forefront of this segment of healthcare, seeking preventive gene treatments to tackle Type 2 diabetes. MannKind Corp. (NASDAQ: MNKD) is offering other innovations for diabetics, with the first inhalation-based drug for managing insulin levels, and Danish multinational Novo Nordisk (NYSE: NVO) offers…

Continue Reading

FridayMar 02, 2018 8:30 am

NetworkNewsAudio – Blockchain Revolution Shines Light on Global Payout, Inc. (GOHE)

Related Editorial Change is coming in the financial sector. The desire for faster payments and better audit trails is leading companies away from traditional payment systems and toward innovation. Blockchain technology is increasingly relevant in this area, with companies such as Global Payout, Inc. (GOHE) (GOHE Profile) applying the technology to improve payment processing and logistics in the financial sector. Mastercard (MA), one of the biggest players in payment processing, has obtained patents to develop its own blockchain systems. Glance Technologies (GLNNF) (GET:CNX), which specializes in payment solutions for customers, has partnered with Netcoins Inc. to integrate blockchain-based cryptocurrency payments…

Continue Reading

WednesdayFeb 28, 2018 8:30 am

NetworkNewsAudio – Neutrisci International Inc. (TSX-V: NU) (OTCQB: NRXCF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enter Global Licensing Agreement

Related Press Release NeutriSci International Inc. (TSX-V:NU) (OTCQB:NRXCF) (Frankfurt:1N9) and Lexaria Bioscience Corp. (CSE:LXX) (OTCQX:LXRP) are pleased to announce that they have revised their joint venture agreement such that NeutriSci now owns 100% of Ambarii Trade Corporation, and Lexaria has granted to NeutriSci, an Intellectual Property License and Supply Agreement for the manufacturing and sale of CBD based products. View Original Press Release

Continue Reading

TuesdayFeb 27, 2018 8:30 am

NetworkNewsAudio – Epazz, Inc. (EPAZ) Interview

About Epazz, Inc. Epazz, Inc. (OTC: EPAZ) is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company’s strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to…

Continue Reading

TuesdayFeb 27, 2018 8:30 am

NetworkNewsAudio – SinglePoint, Inc. (SING) Creates Blockchain Innovations to Disrupt Healthcare

Related Editorial Blockchain, the technology behind cryptocurrencies such as bitcoin, boasts tremendous disruptive potential in a wide range of industries, including finance, infrastructure, supply chain management and even healthcare. SinglePoint, Inc. (SING) (SING Profile), a company with diverse interests and skills in the tech sector, has teamed up with ORHub, Inc. (ORHB) (ORHB Profile) to create a blockchain-based solution to improve the way hospitals collect and utilize operating room data to reduce supply chain costs, while IBM (IBM) and the Food and Drug Administration (FDA) are exploring ways of using blockchain to more effectively share and audit medical data. With…

Continue Reading

MondayFeb 26, 2018 8:30 am

NetworkNewsAudio – Rise of Electric Cars Fuels Market Surge for First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

Related Editorial Advocates have long argued that environmentally friendly technologies could provide a boost to any economy. In the past few years, the rise of the electric car has proved them right. Not only is it creating wealth in the manufacturing sector, but it’s having spill-over effects in related industries. The need for cobalt in the manufacture of green car batteries has fueled staggering growth for First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) (FTSSF Profile), with a share price increase of as much as 350 percent in a single year. Behind the showmanship of CEO Elon Musk, Tesla, Inc. (NASDAQ:…

Continue Reading

FridayFeb 23, 2018 8:30 am

NetworkNewsAudio – PreveCeutical Medical Inc.’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Unique Delivery Platform Could be a Breakthrough in Cannabinoid Drug Delivery

Related Editorial Modern science has substantiated both the anecdotal history and the efficacy of cannabidiol (“CBD”), a non-psychoactive compound found in the cannabis sativa plant. Research has revealed that CBD may significantly reduce inflammation and is now widely used to treat chronic pain, multiple sclerosis and fibromyalgia, epilepsy, and numerous other conditions. There is even evidence that CBD has potential to prevent symptoms of Alzheimer's and appears to suppress the growth of cancer cells and promote the death of these cells (http://nnw.fm/S6cXu). While CBD may provide solutions to multiple unmet medical needs, current drug delivery techniques remain antiquated. There are…

Continue Reading

Contact us: 212.418.1217